Drug Availability Update
Further to DrugAlert Vol 510, HPS Pharmacies wish to give notice that Amdipharm Mercury Australia is continuing to experience a supply interruption for tranylcypromine tablets as follows:
Tranylcypromine (as sulfate) 10 mg
Normal supplies are expected to resume in early November 2019. Limited supplies of an internationally registered brand of tranylcypromine tablets is now available under Section 19A of the Therapeutic Goods Act 1989.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Amdipharm Mercury Australia on 1800 627 680, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates